- Home
- ATOS vs FTCI Comparison
ATOS vs FTCI Comparison
Compare ATOS & FTCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- FTCI
- Stock Information
- Founded
- ATOS 2009
- FTCI 2017
- Country
- ATOS United States
- FTCI United States
- Employees
- ATOS N/A
- FTCI N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- FTCI Semiconductors
- Sector
- ATOS Health Care
- FTCI Technology
- Exchange
- ATOS Nasdaq
- FTCI Nasdaq
- Market Cap
- ATOS 107.2M
- FTCI 88.9M
- IPO Year
- ATOS 2012
- FTCI 2021
- Fundamental
- Price
- ATOS $0.78
- FTCI $6.45
- Analyst Decision
- ATOS Strong Buy
- FTCI Buy
- Analyst Count
- ATOS 3
- FTCI 3
- Target Price
- ATOS $6.17
- FTCI $4.67
- AVG Volume (30 Days)
- ATOS 1.3M
- FTCI 130.9K
- Earning Date
- ATOS 08-12-2025
- FTCI 08-05-2025
- Dividend Yield
- ATOS N/A
- FTCI N/A
- EPS Growth
- ATOS N/A
- FTCI N/A
- EPS
- ATOS N/A
- FTCI N/A
- Revenue
- ATOS N/A
- FTCI $64,134,000.00
- Revenue This Year
- ATOS N/A
- FTCI $102.41
- Revenue Next Year
- ATOS N/A
- FTCI $154.53
- P/E Ratio
- ATOS N/A
- FTCI N/A
- Revenue Growth
- ATOS N/A
- FTCI N/A
- 52 Week Low
- ATOS $0.55
- FTCI $2.02
- 52 Week High
- ATOS $1.66
- FTCI $7.40
- Technical
- Relative Strength Index (RSI)
- ATOS 45.59
- FTCI 64.02
- Support Level
- ATOS $0.81
- FTCI $5.10
- Resistance Level
- ATOS $0.80
- FTCI $6.10
- Average True Range (ATR)
- ATOS 0.03
- FTCI 0.61
- MACD
- ATOS -0.00
- FTCI 0.11
- Stochastic Oscillator
- ATOS 39.58
- FTCI 93.12
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About FTCI FTC Solar Inc.
FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.